Institut Pasteur, Molecular Retrovirology Unit, Centre National de la Recherche Scientifique URA3015, 75724 Paris cedex 15, France.
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4858-63. doi: 10.1073/pnas.1009687108. Epub 2011 Mar 2.
The human APOBEC3 (A3A-A3H) locus encodes six cytidine deaminases that edit single-stranded DNA, the result being DNA peppered with uridine. Although several cytidine deaminases are clearly restriction factors for retroviruses and hepadnaviruses, it is not known if APOBEC3 enzymes have roles outside of these settings. It is shown here that both human mitochondrial and nuclear DNA are vulnerable to somatic hypermutation by A3 deaminases, with APOBEC3A standing out among them. The degree of editing is much greater in patients lacking the uracil DNA-glycolyase gene, indicating that the observed levels of editing reflect a dynamic composed of A3 editing and DNA catabolism involving uracil DNA-glycolyase. Nonetheless, hyper- and lightly mutated sequences went hand in hand, raising the hypothesis that recurrent low-level mutation by APOBEC3A could catalyze the transition from a healthy to a cancer genome.
人类 APOBEC3(A3A-A3H)基因座编码六种胞嘧啶脱氨酶,可编辑单链 DNA,结果是 DNA 中散布着尿嘧啶。尽管几种胞嘧啶脱氨酶显然是逆转录病毒和嗜肝 DNA 病毒的限制因素,但 APOBEC3 酶在这些环境之外是否具有作用尚不清楚。这里表明,人类线粒体和核 DNA 都容易受到 A3 脱氨酶的体细胞超突变,其中 APOBEC3A 尤为突出。在缺乏尿嘧啶 DNA-糖基化酶基因的患者中,编辑程度要大得多,这表明观察到的编辑水平反映了由 A3 编辑和涉及尿嘧啶 DNA-糖基化酶的 DNA 分解代谢组成的动态过程。尽管如此,高编辑和低编辑序列并存,这提出了一个假设,即 APOBEC3A 的反复低水平突变可能催化从健康基因组向癌症基因组的转变。